217 related articles for article (PubMed ID: 18759057)
1. The role of procalcitonin in febrile neutropenic patients: review of the literature.
Sakr Y; Sponholz C; Tuche F; Brunkhorst F; Reinhart K
Infection; 2008 Oct; 36(5):396-407. PubMed ID: 18759057
[TBL] [Abstract][Full Text] [Related]
2. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
3. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
5. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.
Jimeno A; García-Velasco A; del Val O; González-Billalabeitia E; Hernando S; Hernández R; Sánchez-Muñoz A; López-Martín A; Durán I; Robles L; Cortés-Funes H; Paz-Ares L
Cancer; 2004 Jun; 100(11):2462-9. PubMed ID: 15160353
[TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Almela M; Puig de la Bellacasa J; Carreras E; Mensa J
Br J Haematol; 2004 Aug; 126(3):372-6. PubMed ID: 15257709
[TBL] [Abstract][Full Text] [Related]
7. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
8. Serial procalcitonin levels to detect bacteremia in febrile neutropenia.
Reitman AJ; Pisk RM; Gates JV; Ozeran JD
Clin Pediatr (Phila); 2012 Dec; 51(12):1175-83. PubMed ID: 23034950
[TBL] [Abstract][Full Text] [Related]
9. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
Shomali W; Hachem R; Chaftari AM; Jiang Y; Bahu R; Jabbour J; Raad S; Al Shuaibi M; Al Wohoush I; Raad I
Cancer; 2012 Dec; 118(23):5823-9. PubMed ID: 22605389
[TBL] [Abstract][Full Text] [Related]
10. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.
Vänskä M; Koivula I; Jantunen E; Hämäläinen S; Purhonen AK; Pulkki K; Juutilainen A
Cytokine; 2012 Dec; 60(3):787-92. PubMed ID: 22902948
[TBL] [Abstract][Full Text] [Related]
11. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.
Giamarellos-Bourboulis EJ; Grecka P; Poulakou G; Anargyrou K; Katsilambros N; Giamarellou H
Clin Infect Dis; 2001 Jun; 32(12):1718-25. PubMed ID: 11360214
[TBL] [Abstract][Full Text] [Related]
12. Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?
Robinson JO; Lamoth F; Bally F; Knaup M; Calandra T; Marchetti O
PLoS One; 2011 Apr; 6(4):e18886. PubMed ID: 21541027
[TBL] [Abstract][Full Text] [Related]
13. A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin.
Semeraro M; Thomée C; Rolland E; Le Deley MC; Rosselini D; Troalen F; Amoroso L; Dubrel M; Hartmann O
Pediatr Blood Cancer; 2010 Feb; 54(2):284-90. PubMed ID: 19927283
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
[TBL] [Abstract][Full Text] [Related]
15. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?
Schüttrumpf S; Binder L; Hagemann T; Berkovic D; Trümper L; Binder C
Ann Hematol; 2003 Feb; 82(2):98-103. PubMed ID: 12601488
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children.
Lodahl D; Schrøder H
Dan Med Bull; 2011 Mar; 58(3):A4233. PubMed ID: 21371399
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults.
Massaro KS; Costa SF; Leone C; Chamone DA
BMC Infect Dis; 2007 Nov; 7():137. PubMed ID: 18034890
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.
Miedema KG; de Bont ES; Elferink RF; van Vliet MJ; Nijhuis CS; Kamps WA; Tissing WJ
Support Care Cancer; 2011 Oct; 19(10):1593-600. PubMed ID: 20803037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
